It seems we can’t find what you’re looking for. Perhaps searching can help.
1933 - 1999
Odette Cancer Centre – A Phase 2, Open-label, Multicenter, Study of an Immunotherapeutic Treatment, DPX-Survivac in Combination With Low Dose Cyclophosphamide and Pembrolizumab, in Subjects With Selected Advanced and Recurrent Solid Tumours.